Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States.
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Front Immunol. 2018 Dec 4;9:2793. doi: 10.3389/fimmu.2018.02793. eCollection 2018.
Expanding efforts to develop preventive gonorrhea vaccines is critical because of the serious health consequences combined with the prevalence and the dire possibility of untreatable gonorrhea. Reverse vaccinology, which includes genome and proteome mining, has proven successful in the discovery of vaccine candidates against many pathogenic bacteria. Here, we describe proteomic applications including comprehensive, quantitative proteomic platforms and immunoproteomics coupled with broad-ranging bioinformatics that have been applied for antigen mining to develop gonorrhea vaccine(s). We further focus on outlining the vaccine candidate decision tree, describe the structure-function of novel proteome-derived antigens as well as ways to gain insights into their roles in the cell envelope, and underscore new lessons learned about the fascinating biology of .
扩大预防淋病疫苗的研发力度至关重要,因为淋病不仅发病率高,而且存在无法治愈的严重健康风险。反向疫苗学包括基因组和蛋白质组学挖掘,已被证明在发现针对许多病原菌的疫苗候选物方面取得了成功。在这里,我们描述了蛋白质组学应用,包括全面、定量的蛋白质组学平台和免疫蛋白质组学,以及广泛的生物信息学,这些都已应用于抗原挖掘以开发淋病疫苗。我们进一步重点介绍了疫苗候选物决策树,描述了新型蛋白质组衍生抗原的结构-功能,以及深入了解它们在细胞包膜中的作用的方法,并强调了关于淋病生物学的迷人新认识。